Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 133-138

  Zang, Xiao Ping ^a   Pento, J Thomas ^a   Tari, Ana M ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer cell motility; Erk1,2; FAK; Grb2; KGF; WT1

Indexed keywords

FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; KERATINOCYTE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; WT1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER MORTALITY; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 7; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GRB2 ADAPTOR PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEAR PROTEINS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 40549145147     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802-806, 1989.
2. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cunha GR and Finch PW: Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. EXS 74: 191-214, 1995.
3. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D and Aaronson SA: Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251: 72-75, 1991.
4. Celli G, LaRochelle WJ, Mackem S, Sharp R and Merlino G: Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 17: 1642-1655, 1998.
5. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG and Rubin JS: Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 638: 62-77, 1991.
6. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C and Aaronson SA: Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 265: 12767-12770, 1990.
7. Zang XP, Lerner ML, Brackett DJ and Pento JT: KGF-induced gene expression in MCF-7 cells using cDNA expression arrays. Breast Cancer Res Treat 58: 110, 2000.
8. Zang XP and Pento JT: Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis 18: 573-580, 2000.
9. Zang XP, Siwak DR, Nguyen TX, Tari AM and Pento JT: KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exp Metastasis 21: 437-443, 2004.
10. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C and Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
11. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC and Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61: 1257-1269, 1990.
12. Lee S and Haber DA: Wilms Tumor and the WT1 gene. Exp Cell Res 264: 74-99, 2001.
13. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T and Sugiyama H: Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia. Blood 89: 1405-1412, 1997.
14. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I and Sugiyama H: Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100: 297-303, 2002.
15. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H and Noguchi S: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167-1171, 2002.
16. Tuna M, Chavez-Reyes A and Tari AM: HER2/neu increases the expression of Wilms' tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 24: 1648-1652, 2005.
17. Schlaepfer DD, Hanks SK, Hunter T and van der Geer P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372: 786-791, 1994.
18. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, Nakazawa T, Tatsumi N, Sakaguchi N, Takashima S, Shirakata T, Nishida S, Hosen N, Kawakami M, Tsuboi A, Oka Y, Itoh K and Sugiyama H: Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97: 259-270, 2006.
19. Rajah TT, Rambo DJ, Dmytryk JJ and Pento JT: Influence of antiestrogens on NIH-3T3-fibroblast-induced motility of breast cancer cells. Chemotherapy 47: 56-69, 2001.
20. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5: 505-515, 2005.
21. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M and Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544, 1995.
22. Gilmore AP and Romer LH: Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7: 1209-1224, 1996.
23. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256, 2000.
24. Zhao JH, Reiske H and Guan JL: Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 143: 1997-2008, 1998.
25. Shen TL and Guan JL: Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett 499: 176-181, 2001.
26. Aguirre Ghiso JA: Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21: 2513-2524, 2002.
27. Hecker TP, Grammer JR, Gillespie GY, Stewart J Jr and Gladson CL: Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res 62: 2699-2707, 2002.
28. Zhang W, Wu N, Li Z, Wang L, Jin J and Zha XL: PPARgamma activator rosiglitazone inhibits cell migration via up-regulation of PTEN in human hepatocarcinoma cell line BEL-7404. Cancer Biol Ther 5: 1008-1014, 2006.
29. Manni A, Washington S, Mauger D, Hackett DA and Verderame MF: Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells. Clin Exp Metastasis 21: 461-467, 2004.
30. Yang J, Price MA, Neudauer CL, Wilson C, Ferrone S, Xia H, Iida J, Simpson MA and McCarthy JB: Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J Cell Biol 165: 881-891, 2004.